Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05255302
Title De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction (DIAL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Intergroupe Francophone de Cancerologie Thoracique
Age Groups: senior | adult
Covered Countries FRA

Additional content available in CKB BOOST